YAMAMOTO LAB
National Cerebral and Cardiovascular Center
News
News
2023/05/10
New Publication in Communications Biology by Dr. Yamamoto, Dr. Choi and Mr. Matoba "The SGLT2 inhibitor empagliflozin improves cardiac energy status via mitochondrial ATP production in diabetic mice"
2022/05/18
Our website is now open!